ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "infliximab and spondylarthritis"

  • Abstract Number: 721 • ACR/ARHP Annual Meeting 2016

    Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study

    Alberto Batticciotto1,2, Marco Antivalle2, Francesca Li Gobbi3, Simone Parisi4, Rossella Talotta2, Valentina Varisco2, Maurizio Benucci3, Enrico Fusaro4 and Piercarlo Sarzi-Puttini1, 1Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 2Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, 3Rheumatology Unit, Ospedale S. Giovanni di Dio, Florence, Florence, Italy, 4Department of Rheumatology, University Hospital Città Della Salute e della Scienza di Torino, Turin, Italy

    Background/Purpose: Biosimilar infliximab (INX) was recently approved by the European Medicine Agency based on comparable pharmacokinetics, safety and efficacy profile to innovator INX for the…
  • Abstract Number: 2881 • ACR/ARHP Annual Meeting 2015

    Infliximab in Spondyloarthritis Patients: Utility of Drug Level Monitoring

    Claudia Deaconu1, Diana Mazilu2, Laura Grosanu2, Ioana Saulescu2, Andreea Borangiu2, Cecilia Gainaru3, Cosmin Constantinescu2, Violeta Bojinca2, Violeta Vlad1, Andra Balanescu2, Denisa Predeteanu2, Ruxandra Ionescu2 and Daniela Opris2, 1Department of Internal Medicine and Rheumatology “Sf. Maria” Hospital, Bucharest, Romania, 2University of Medicine and Pharmacy “Carol Davila”, Department of Internal Medicine and Rheumatology “Sf. Maria” Hospital, Bucharest, Romania, 3"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania

    Background/Purpose: Spondyloarthritides, a heterogeneous group of chronic, inflammatory disorders with overlapping organ and joint targeting, share the same therapeutic approach in regard to biological therapy.…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology